XML 95 R79.htm IDEA: XBRL DOCUMENT v3.20.4
Parent Company Only Financial Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Investment in unconsolidated subsidiaries:                                      
Other assets                               $ 1,520,757,000 $ 1,220,435,000    
Total assets                               34,932,860,000 27,805,496,000    
Liabilities and Equity [Abstract]                                      
Subordinated debt and other borrowings                               670,575,000 749,080,000    
Other Liabilities                               411,074,000 288,569,000    
Stockholders' equity                               4,904,611,000 4,355,748,000 $ 3,965,940,000 $ 3,707,952,000
Total liabilities and stockholders' equity                               34,932,860,000 27,805,496,000    
Expenses:                                      
Interest expense - subordinated debentures                         $ 199,254,000 $ 301,794,000 $ 210,375,000        
Personnel expense, including stock compensation                         334,483,000 313,359,000 271,673,000        
Income tax expense (benefit)                         59,037,000 96,656,000 90,508,000        
Net income $ 110,876,000 $ 110,645,000 $ 62,444,000 $ 28,356,000                 312,321,000 400,881,000 359,440,000        
Preferred stock dividends                         7,596,000 0 0        
Net income available to common shareholders 107,078,000 106,847,000 62,444,000 28,356,000 $ 96,079,000 $ 110,521,000 $ 100,321,000 $ 93,960,000 $ 95,318,000 $ 93,747,000 $ 86,865,000 $ 83,510,000 304,725,000 400,881,000 359,440,000        
CONDENSED STATEMENTS OF CASH FLOWS [Abstract]                                      
Net income 110,876,000 $ 110,645,000 $ 62,444,000 28,356,000                 312,321,000 400,881,000 359,440,000        
Adjustments to reconcile net income to net cash provided by operating activities:                                        
Depreciation, amortization and accretion                         45,203,000 8,342,000 (23,604,000)        
Stock-based compensation expense                         18,737,000 21,226,000 17,636,000        
Deferred tax (expense) benefit                         (58,315,000) 14,696,000 11,765,000        
Income from equity method investment                         (83,539,000) (90,111,000) (51,222,000)        
Dividends received from equity method investment                         53,020,000 51,312,000 33,651,000        
Excess tax benefit from stock compensation                         (417,000) (1,011,000) (2,966,000)        
(Increase) decrease in other assets                         (157,294,000) (57,499,000) (24,471,000)        
Increase in other liabilities                         81,322,000 79,264,000 60,617,000        
Net cash provided by operating activities                         427,825,000 434,288,000 470,757,000        
Investing activities:                                      
Increase in other investments                         (71,254,000) (55,926,000) (56,918,000)        
Net cash used in investing activities                         (3,568,662,000) (2,619,061,000) (2,969,084,000)        
Financing activities:                                      
Repayments of other borrowings                         136,661,000 184,175,000 620,000        
Issuance of common stock pursuant to restricted stock unit agreement, net of shares withheld for taxes                         (2,488,000) 0 0        
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants                         217,126,000 0 0        
Repurchase of common stock                         (50,790,000) (61,416,000) (20,694,000)        
Common dividends paid                         49,389,000 49,828,000 45,454,000        
Preferred stock dividends paid                         7,596,000 0 0        
Net cash provided by financing activities                         6,575,579,000 1,989,788,000 2,440,423,000        
Investment Income, Dividend                         119,100,000 114,000,000.0 83,100,000        
Parent Company                                      
Assets [Abstract]                                      
Cash and cash equivalents 275,888,000     182,091,000 182,091,000     94,043,000 94,043,000     64,851,000 182,091,000 94,043,000 64,851,000 275,888,000 182,091,000 $ 94,043,000 $ 64,851,000
Investment in unconsolidated subsidiaries:                                      
Unconsolidated subsidiaries                               3,995,000 3,995,000    
Other investments                               113,445,000 97,459,000    
Current income tax receivable                               51,621,000 11,696,000    
Other assets                               25,747,000 29,566,000    
Total assets                               5,452,178,000 4,985,933,000    
Liabilities and Equity [Abstract]                                      
Taxes Payable                               0 2,467,000    
Subordinated debt and other borrowings                               541,286,000 620,256,000    
Other Liabilities                               6,281,000 7,462,000    
Stockholders' equity                               4,904,611,000 4,355,748,000    
Total liabilities and stockholders' equity                               5,452,178,000 4,985,933,000    
CONDENSED STATEMENTS OF OPERATIONS [Abstract]                                      
Income from equity method investment                         22,587,000 24,298,000 13,731,000        
Other income (loss)                         3,861,000 3,485,000 1,310,000        
Expenses:                                      
Interest expense - subordinated debentures                         23,877,000 18,425,000 17,703,000        
Personnel expense, including stock compensation                         18,737,000 21,226,000 17,636,000        
Other expense                         2,905,000 1,496,000 1,312,000        
Income before income taxes and equity in undistributed income of subsidiaries                         100,113,000 100,796,000 61,650,000        
Income tax expense (benefit)                         (5,370,000) (4,457,000) (8,570,000)        
Income before equity in undistributed income of subsidiaries                         105,483,000 105,253,000 70,220,000        
Equity in undistributed income of bank subsidiaries                         205,327,000 294,354,000 288,728,000        
Equity in undistributed income (loss) of nonbank subsidiaries                         1,511,000 1,274,000 492,000        
Net income                         312,321,000 400,881,000 359,440,000        
Preferred stock dividends                         7,596,000 0 0        
Net income available to common shareholders                         304,725,000 400,881,000 359,440,000        
CONDENSED STATEMENTS OF CASH FLOWS [Abstract]                                      
Net income                         312,321,000 400,881,000 359,440,000        
Adjustments to reconcile net income to net cash provided by operating activities:                                        
Depreciation, amortization and accretion                         1,122,000 (3,094,000) 105,000        
Stock-based compensation expense                         18,737,000 21,226,000 17,636,000        
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable                         (2,467,000) 2,467,000 (24,000)        
Deferred tax (expense) benefit                         3,876,000 (2,857,000) (549,000)        
Income from equity method investment                         (22,587,000) (24,298,000) (13,731,000)        
Dividends received from equity method investment                         9,251,000 8,953,000 5,872,000        
Excess tax benefit from stock compensation                         (417,000) (1,011,000) (2,966,000)        
Gain on other investments                         (195,000) (1,057,000) (209,000)        
(Increase) decrease in other assets                         (39,981,000) 7,295,000 4,390,000        
Increase in other liabilities                         (764,000) 5,322,000 2,758,000        
Equity in undistributed (income) loss of bank subsidiaries                         (205,327,000) (294,354,000) (288,728,000)        
Equity in undistributed (income) loss of nonbank subsidiaries                         (1,511,000) (1,274,000) (492,000)        
Net cash provided by operating activities                         72,058,000 118,199,000 83,502,000        
Investing activities:                                      
Investment in consolidated banking subsidiaries                         0 (180,000,000) 0        
Increase in other investments                         (2,454,000) (1,411,000) (2,321,000)        
Net cash used in investing activities                         (2,454,000) (181,411,000) (2,321,000)        
Proceeds from (Repayments of) Debt                         (93,000) 316,078,000 19,850,000        
Financing activities:                                      
Repayments of other borrowings                         80,000,000 49,880,000 620,000        
Issuance of common stock pursuant to restricted stock unit agreement, net of shares withheld for taxes                         (2,488,000) 0 0        
Exercise of common stock options, net of shares surrendered for taxes                         (2,577,000) (3,694,000) (5,071,000)        
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants                         217,126,000 0 0        
Repurchase of common stock                         (50,790,000) (61,416,000) (20,694,000)        
Common dividends paid                         (49,389,000) (49,828,000) (45,454,000)        
Preferred stock dividends paid                         (7,596,000) 0 0        
Net cash provided by financing activities                         24,193,000 151,260,000 (51,989,000)        
Cash and Cash Equivalents, Period Increase (Decrease)                         93,797,000 88,048,000 29,192,000        
Cash and cash equivalents, beginning of year       $ 182,091,000       $ 94,043,000       $ 64,851,000 182,091,000 94,043,000 64,851,000        
Cash and cash equivalents, end of year $ 275,888,000       $ 182,091,000       $ 94,043,000       275,888,000 182,091,000 94,043,000        
Banking                                      
Assets [Abstract]                                      
Investments in consolidated subsidiaries                               4,972,160,000 4,653,310,000    
CONDENSED STATEMENTS OF OPERATIONS [Abstract]                                      
Income from bank subsidiaries                         119,065,000 113,982,000 83,090,000        
Nonbank subsidiaries                                      
Assets [Abstract]                                      
Investments in consolidated subsidiaries                               $ 9,322,000 $ 7,816,000    
CONDENSED STATEMENTS OF OPERATIONS [Abstract]                                      
Income from bank subsidiaries                         $ 119,000 $ 178,000 $ 170,000